Search


Utrecht University
- 2 min
Utrecht Centre of Excellence for Affordable Biotherapeutics
Utrecht University (The Netherlands) and the World Health Organisation (WHO) will work together to make affordable patent-free medicines possible in developing countries. To this end, both organisations signed an agreement on 2 March in which the university makes knowledge available under strict conditions for the production of such medicines. The WHO approached Utrecht University partly as a result of the leading knowledge position of the university in this area. “This speci


selected & edited by #pharmanaming.com
- 1 min
Actavis changes name in Allergan
From www.dddmag.com – February 18, 2015 Actavis will change the company name after the completed acquisition of Allergan. Actavis, the world’s third-largest generics prescription drug manufacturer, also markets a broad portfolio of branded pharmaceuticals and is developing and marketing biosimilars. After the acquisition of Allergan, producer of the successful Botox, Actavis announced that it intends to use the Allergan name as its corporate name and for its global branded ph